Tls Advisors LLC Ovid Therapeutics Inc. Transaction History
Tls Advisors LLC
- $44.3 Million
- Q1 2025
A detailed history of Tls Advisors LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Tls Advisors LLC holds 680,967 shares of OVID stock, worth $217,909. This represents 0.48% of its overall portfolio holdings.
Number of Shares
680,967
Previous 680,967
-0.0%
Holding current value
$217,909
Previous $636,000
66.51%
% of portfolio
0.48%
Previous 1.45%
Shares
6 transactions
Others Institutions Holding OVID
# of Institutions
83Shares Held
39.8MCall Options Held
1.7KPut Options Held
100-
Rubric Capital Management LP New York, NY5.32MShares$1.7 Million0.05% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$1.28 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$1.23 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.11MShares$994,8090.0% of portfolio
-
Madison Avenue Partners, LP New York, NY2.47MShares$788,9990.1% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $22.5M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...